Stay updated on Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Sign up to get notified when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.

Latest updates to the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has been updated to include the EudraCT number for the study and the name of the collaborator, GlaxoSmithKline, while significant details about the study's design, inclusion and exclusion criteria have been removed.SummaryDifference10%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.3%
- Check77 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.3%
- Check85 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Enter your email address, and we'll notify you when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.